Trough level testing to improve patient care
USZ Anti-drug antibodies and trough levels: Adalimumab, Certolizumab, Golimumab, Infliximab & Vedolizumab
To furhter improve patient care, the University Hospital Zurich offers now several diagnsotic tests to measure biologics trough-levels and anti-drug antibodies of Adalimumab, Certolizumab, Golimumab and Infliximab.
Test description:
Adalimumab (french)
Certolizumab (french)
Goliumab (french)
Infliximab (french)
Vedolizumab
Test procedure:
auf Deutsch
Order Form USZ:
auf Deutsch
Trough Level Testing: Lisa Tracker from Theradiag at CHUV
Serum drug level and anti-drug antibody + TNFalpha Testing
from THERADIAG are available at Lausanne University Hospital:
Test Description Theradiag (french)
Information of how to proceed to get a test done:
auf Deutsch en français
Order Form CHUV:
auf Deutsch en français
Promonitor from Progenika at Unilabs
Serum Level and Antibody Testing for Infliximab (and Adalimumab)
and also free TNFalpha
from PROMONITOR are available at Unilabs:
Information of how to proceed to get a test done:
auf Deutsch and en français
Order Form Unilabs
auf Deutsch and en français
Currently, no clear guidelines exist on the interpretation of the results of these tests. For questions on the clinical use and challenges in interpreting results, Michel Maillard ist available for discussions.